Favipiravir, Developed By A Japanese Manufacturer, Has Already Been Tested In More Than 120 Patients With Confirmed Improvement.
Approval by malaysia expands availability and means that avigan® is now available to treat more than 3 billion people in china, indonesia, india and malaysia. To estimate and forecast the market size of asia pacific favipiravir market from 2020 to 2026 and growth rate until 2026. Some common side effects of the fabiflu are swelling all over the body, muscle pain, asthma attack, gastrointestinal upset, miscarriages, hay fever, and allergic dermatitis.
Favipiravir, Sold Under The Brand Name Avigan Among Others, Is An Antiviral Medication Used To Treat Influenza In Japan.
This study revealed that favipiravir appears to be a relatively safe drug. To identify dominant region or segment in the asia pacific favipiravir market. It serves as a public reference to purchase medicines in the private sector.
This study analyzed all suspected ades related to. Consumer price guide (cpg) is a list of medicine prices. To classify and forecast asia pacific favipiravir market based on type, distribution channel, application, company and regional distribution.
Currently, The Data Is Based On Very Few Patients.
Almost 1 million favipiravir pills are taken daily in thailand. It is being developed and manufactured by toyama chemical. A more detailed assessment o.
The Information Provide Medicine Availability And Market Price Guidance For Consumers To Make Informed Choices.
The report is prepared based on information available at the time of research and a limited literature. Avigan (favipiravir) was approved for manufacture and. Avigan (favipiravir) antiviral description for 2022.
